Hyperactivation of mitogen-activated protein kinase increases phospho- tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities

Cellular and Molecular Neurobiology

Volumn 19, Issue 2, 1999, Pages 249-260

  Ekinci, Fatma J ^a   Shea, Thomas B ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Alzheimer's disease; MAP kinase; Neuroblastoma; PD98059; Protein kinase C; Tau; Wortmannin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM IONOPHORE; MITOGEN ACTIVATED PROTEIN KINASE; WORTMANNIN;

ALZHEIMER DISEASE; ANTIGEN BINDING; ARTICLE; CELL CULTURE; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANDROSTADIENES; BRAIN; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEUROBLASTOMA; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032972004     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006981228331     Document Type: Article

References (58)

1. Arioka, M., Tsukamoto, M., Ishiguro, K., Kato, R., Sato, K., Imahori, K., and Uchida, T. (1993). Tau protein kinase-1 is involved in the regulation of the normal phosphorylation state of tau protein. J. Neurochem. 60:461-468.
2. Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seiteberger, F., Grundke-Iqbal, I., Iqbal, I., and Wisniewski, H. M. (1989). Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:90-99.
3. Baudier, J., and Cole, R. D. (1987). Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. Biol. Chem. 262:17577-17583.
4. Blanchard, B. J., Raghunandan, R. D., Roder, H. M., and Ingram, V. M. (1994). Hyperphosphorylation of human tau by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: Relation to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:187-194.
5. Boyce, J. J., and Shea, T. B. (1997). Phosphorylation events mediated by protein kinase Ca and e participate in the regulation of tau steady-state levels and generation of certain "Alzheimer-like" phospho-epitopes. Int. J. Dev. Neurosci. 15:295-307.
6. Clark, E. A., Leach, K. L., Trojanowski, J. Q., and Lee, V. M. (1991). Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. Lab. Invest. 64:35-44.
7. Cressman, C. M., and Shea, T. B. (1995). Hyperphosphorylation of tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. J. Neurosci. Res. 42:648-656.
8. Cressman, C. M., Boyce, J. B., Wheeler, E., Chang, M., and Shea, T. B. (1995). Site-specific synergism between PKC and MAP kinase in tau hyperphosphorylation in intact SH-SY-5Y human neuroblastoma. J. Neurochem. 67 (Suppl.):S62.
9. Ekinci, F. J., and Shea, T. B. (1997). Tau phosphorylation is regulated by divergent and convergent signal transduction pathways. J. Neurochem. 69 (Suppl.):S208.
10. Felsenstein, K. M., Ingalls, K. M., Hunihan, L. W., and Roberts, S. B. (1994). Reversal of the Swedish familial Alzheimer's disease mutant phenotype in cultured cells treated with phorbol 12,13-dibutyrate. Neurosci. Lett. 174:173-176.
11. Fowler, C. J., Cowburn, R. F., Garlind, A., Winblad, B., and O'Neill, C. (1995). Disturbances in signal transduction mechanisms in Alzheimer's disease. Mol. Cell. Biochem. 149-150:287-292.
12. Goedert, M., Jakes, R., Crowther, R. A., Six, J., Lubke, U., Vandermeeren, M., Cras, P., Trojanowski, J. Q., and Lee, V. M.-Y. (1993). The abnormal phosphorylation of tau proteins at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. USA 90:5066-5070.
13. Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelein, E., Vandermeeren, M., and Cras, P. (1994). Epitope mapped protein tau are dephosphorylated by protein phosphatase 2A-1. FEBS Lett. 312:195-199.
14. Govoni, S., Bergamaschi, S., Racchi, M., Battaini, F., Binetti, G., Bianchetti, A., and Trabucchi, M. (1993). Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology 43:2581-2586.
15. Govoni, S., Racchi, M., Bergamaschi, S., Trabucchi, M., Battaini, F., Bianchetti, A., and Binetti, G. (1996). Defective protein kinase C alpha leads to impaired secretion of soluble beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Ann. N.Y. Acad. Sci. 777:332-337.
16. Hong, M., and Lee, V. M.-Y. (1997). Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272:19547-19553.
17. Imahori, K., and Uchida, T. (1997). Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo) 121:179-188.
18. 2+/calmodulin-dependent protein kinase II. J. Neurosci. Res. 34:642-647.
19. Kobayashi, S., Ishiguro, K., Omori, A., Takamatsu, M., Arioka, M., Imahora, K., and Uchida, T. (1993). A cdc-related kinase PSSALRE/cdk5 is homologous with the 30kDa subunit of tau protein kinase II, a proline-directed kinase associated with microtubules. FEBS Lett. 335:171-175.
20. Kosik, K. S., and Greenberg, S. M. (1994). Tau protein and Alzheimer's disease. In Terry, R. D., Katzman, R., and Bick, K. L. (eds.), Alzheimer's Disease, Raven Press, New York, pp. 335-344.
21. Lanius, R. A., Wagey, R., Sahl, B., Beattie, B. L., Feldman, H., Pelech, S. L., and Krieger, C. (1997). Protein kinase C activity and protein levels in Alzheimer's disease. Brain Res. 764:75-80.
22. Latimer, D. A., Gallo, J.-M., Lovestone, S., Miller, C. C. J., Reynolds, C. H., Marquardt, B., Stable, S., Woodgett, J. R., and Anderton, B. H. (1995). Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett. 365:42-46.
23. Ledesma, M. D., Correase, I., Avila, J., and Diaz-Nido, J. (1992). Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308:218-224.
24. Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J. R., and Miller, C. C. J. (1994). Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1077-1086.
25. Lu, Q., Soria, J. P., and Wood, J. G. (1993). p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J. Neurosci Res. 35:439-444.
26. Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., and Mandelkow, E. (1995). Tau domains, phosphorylation and interactions with microtubules. Neurobiol. Aging 16:355-362.
27. Masliah, E., Cole, G. M., Hansen, L. A., Mallory, M., Albright, T., Terry, R. D., and Saitoh, T. (1991). Protein kinase C alteration is an early biochemical marker in Alzheimer's disease. J. Neurosci. 11:2759-2767.
28. 2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease. J. Neurochem. 67:317-323.
29. Mattson, M. P. (1991). Evidence for the involvement of protein kinase C in neurodegenerative changes in cultured human cortical neurons. Exp. Neurol. 112:95-103.
30. Mattson, M. P., Guthrie, P. B., and Kater, S. B. (1988). Intracellular messengers in the generation and degeneration of hippocampal architecture. J. Neurosci. Res. 20:447-464.
31. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titanti, K., and Ihara, Y. (1995). Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270:823-829.
32. Munoz-Montano, J. R., Moreno, F. J., Avila, J., and Diaz-Nido, J. (1995). Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411:183-188.
33. Parrizas, M., Saltiel, A. R., and LeRoith, D. (1997). Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:154-161.
34. Pei, J.-J., Sersen, E., Iqbal, K., and Grundke-Iqbal, I. (1994). Expression of protein phosphatases (PP1, PP2A, PP2-B, and FTP-1B) and protein kinases (MAP kinase and p34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res. 655:70-76.
35. Pope, W. B., Enam, S. A., Bawa, N., Miller, B. E., Ghanbari, H. A., and Klein, W. L. (1993). Phosphorylated tau epitope of Alzheimer's disease is coupled to axon development in the avian central nervous system. Exp. Neurol. 120:106-113.
36. Pope, W. B., Lambert, M. P., Leypold, B., Seupaul, R., Sletten, L., Krafft, G., and Klein, W. L. (1994). Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY-5Y. Exp. Neurol. 126:185-194.
37. Pundreddy, S., and Shea, T. B. (1997). AD-like tau phosphorylation in human neuroblastoma cells following PKC hyperactivation is mediated by MAP kinase. Neur. Res. Comm. 21:173-177.
38. Raghunandan, R., and Ingram, V. M. (1995). Hyperphosphorylation of the cytoskeletal protein tau by the MAP-kinase PK40erk: Regulation by prior phosphorylation with cAMP-dependent protein kinase A. Biochem. Biophys. Res. Commun. 215:1056-1066.
39. Saitoh, T., Cole, G., and Huynh, T. V. (1990). Aberrant protein kinase C cascades in Alzheimer's disease. Adv. Exp. Med. Biol. 265:301-310.
40. Sengupta, A., Wu, Q., Grundke-Iqbal, I., Iqbal, K., and Singh, T. J. (1997). Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 167:99-105.
41. Shea, T. B. (1997). Phosphatidyl serine alters tau antigenicity, phosphorylation, proteolysis and association with microtubules: Implication for tau function under normal and degenerative conditions. J. Neurosci. Res. 50:114-122.
42. Shea, T. B., and Cressman, C. M. (1999). The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes. Cell. Mol. Neurobiol. 19:223-233.
43. Shea, T. B., Klinger, E. P., and Cressman, C. M. (1995a). Calcium influx recruits an additional class of kinases to hyperphosphorylate tau. Neuroreport 6:1437-1440.
44. Shea, T. B., Beermann, M. L., Spencer, M. A., and Nixon, R. A. (1995b). Enhancement of neurite outgrowth following calpain inhibition is mediated by protein kinase C. J. Neurochem. 65:517-527.
45. Shea, T. B., Spencer, M. J., Beermann, M. L., Cressman, C. M., and Nixon, R. A. (1996). Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: Involvement of calpain-mediated hydrolysis of protein kinase C. J. Neurochem. 66:1539-1549.
46. Shea, T. B., Parabhakar, S., and Ekinci, F. J. (1997). β-Amyloid and ionophore-mediated calcium influx evoke neurodegeneration by distinct intracellular pathways: Differential involvement of the calpain/ protein kinase C system. J. Neurosci. Res. 49:759-768.
47. Shimohama, S., and Matsushima, H. (1995). Signal transduction mechanisms in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9:15-22.
48. Shpetner, H., Joly, M., Hartley, D., and Corvera, S. (1997). Potential sites of PI-3 function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132:595-605.
49. Singh, T. J., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1994a). Modulation of GSK-3 catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Lett. 358:4-8.
50. Singh, T. J., Haque, N., Grundke-Iqbal, I., and Iqbal, K. (1994b). Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline dependent kinase and GSK-3. FEBS Lett. 358:267-272.
51. 2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J. 9:3539-3544.
52. Tanaka, T., Iqbal, K., Trenkner, E., Liu, D. J., and Grundke-Iqbal, I. (1995). Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett. 360:5-9.
53. Trojanowski, J. Q., Schmidt, M. L., Shin, R.-W., Bramblett, G. T., Rao, D., and Lee, V. M.-Y. (1993a). Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3:45-54.
54. Trojanowski, J. Q., Schmidt, M. L., Shin, R.-W., Bramblett, G. T., Goedert, M., and Lee, V. M.-Y. (1993b). PHF tau (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin. Neurosci. 1:184-191.
55. VanRenterghem, B., Browning, M. D., and Maller, J. L. (1994). Regulation of mitogen-activated protein kinase activation by protein kinases A and C in a cell-free system. J. Biol. Chem. 269:24666-24672.
56. Vincent, I., Jicha, G., Rosado, M., and Dickson, D. W. (1997). Aberrant expression of mitotic Cdc2/ cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17:3588-3596.
57. Wang, H. Y., Pisano, M. R., and Friedman, E. (1994). Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol. Aging 15:293-298.
58. Wood, J. G., Lu, Q., Reich, C., and Zinsmeister, P. (1993). Proline-directed kinase systems in Alzheimer's disease pathology. Neurosci. Lett. 156:83-86.